Nu Skin Enterprises (NUS) Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View NUS analyst ratings or view top-rated stocks.

3 Wall Street research analysts have issued twelve-month price objectives for Nu Skin Enterprises' shares. Their NUS share price forecasts range from $38.00 to $41.00. On average, they predict the company's stock price to reach $39.33 in the next twelve months. This suggests a possible upside of 14.1% from the stock's current price.
View analysts price targets for NUS or view top-rated stocks among Wall Street analysts.

Nu Skin Enterprises' stock was trading at $42.16 at the beginning of the year. Since then, NUS shares have decreased by 18.2% and is now trading at $34.47.
View the best growth stocks for 2023 here.

Nu Skin Enterprises saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 1,870,000 shares, a decline of 18.0% from the April 30th total of 2,280,000 shares. Based on an average daily trading volume, of 388,900 shares, the days-to-cover ratio is currently 4.8 days. Currently, 3.8% of the shares of the company are short sold.
View Nu Skin Enterprises' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our NUS earnings forecast.

Nu Skin Enterprises, Inc. (NYSE:NUS) posted its quarterly earnings results on Wednesday, May, 3rd. The company reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.04. The firm had revenue of $481.50 million for the quarter, compared to analysts' expectations of $477.49 million. Nu Skin Enterprises had a trailing twelve-month return on equity of 14.13% and a net margin of 3.68%. The firm's revenue was down 20.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.76 EPS.

Nu Skin Enterprises declared a quarterly dividend on Sunday, April 30th. Investors of record on Friday, May 26th will be given a dividend of $0.39 per share on Wednesday, June 7th. This represents a $1.56 dividend on an annualized basis and a yield of 4.53%. The ex-dividend date of this dividend is Thursday, May 25th.
Read our dividend analysis for NUS.

ETFs with the largest weight of Nu Skin Enterprises (NYSE:NUS) stock in their portfolio include Timothy Plan Market Neutral ETF (TPMN), Invesco S&P SmallCap Consumer Staples ETF (PSCC), Invesco High Yield Equity Dividend Achievers ETF (PEY), Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD), SPDR S&P Dividend ETF (SDY), ProShares Russell 2000 Dividend Growers ETF (SMDV), Global X Health & Wellness ETF (BFIT) and VictoryShares US Small Cap High Div Volatility Wtd ETF (CSB).

Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $1.56 per share and currently has a dividend yield of 4.40%. NUS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 23 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 101.30%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, NUS will have a dividend payout ratio of 55.71% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NUS.

Nu Skin Enterprises updated its second quarter 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of $0.45-$0.55 for the period, compared to the consensus estimate of $0.61. The company issued revenue guidance of $485.00 million-$525.00 million, compared to the consensus revenue estimate of $526.75 million.

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife (HLF), Mastercard (MA) and Netflix (NFLX).

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Nu Skin Enterprises' stock is owned by a number of retail and institutional investors. Top institutional investors include State Street Corp (20.82%), BlackRock Inc. (16.70%), Wellington Management Group LLP (7.42%), Renaissance Technologies LLC (4.62%), Dimensional Fund Advisors LP (4.24%) and Geode Capital Management LLC (2.03%). Insiders that own company stock include Andrew D Lipman, D Matthew Dorny, Edwina D Woodbury, Emma S Battle, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski, Steven Keith Hatchett and Steven Lund.
View institutional ownership trends.

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NUS stock can currently be purchased for approximately $34.47.

Nu Skin Enterprises (NYSE:NUS) has a market capitalization of $1.72 billion and generates $2.23 billion in revenue each year. The company earns $104.78 million in net income (profit) each year or $1.54 on an earnings per share basis.

The company employs 3,800 workers across the globe.

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The official website for the company is www.nuskinenterprises.com. The company can be reached via phone at (801) 345-1000, via email at investorrelations@nuskin.com, or via fax at 801-345-5999.